| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Medical Virology, Institute of Medical and Veterinary Science, Frome Road, Adelaide, South Australia 5000, Australia
During latent infection of neurons with herpes simplex virus type 1 (HSV-1), several RNA transcripts of varying abundance arise from a single locus within the virus repeats. The functions of latency-associated transcripts (LATs) are unknown and the relationship between the various RNA species requires further clarification. Reported here is a novel approach to the study of HSV transcripts during latency, based on the increasing realization that cellular and viral RNAs are synthesized and processed by macromolecular complexes that occupy discrete compartments within the nucleoplasm of a cell. High resolution non-isotopic in situ hybridization was used to study the intranuclear topology of HSV-1 LATs in primary sensory neurons of latently infected mice and humans. Low abundance (minor) LATs were localized to sharply defined intranuclear foci of 1 to 3 µm in diameter. On average, there were 2·6 to 2·8 foci/LAT+ neuronal profile (5 µm), representing 13 to 14 foci/cell. In contrast to the focal deployment of minor LATs, the more abundant latency-associated RNAs were distributed diffusely throughout the nucleoplasms of latency infected neurons, with prominent sparing of nucleolar regions. These data establish a foundation for studying the synthesis, processing and transport of LATs in vivo. It should now be possible to investigate the nature of those cellular products which associate with HSV-1 encoded LATs in vivo and thereby determine whether minor LATs are associated with previously characterized macromolecular complexes, such as those responsible for processing of pre-messenger RNA.
Received 11 January 1993;
accepted 3 March 1993.
This article has been cited by other articles:
|
|
 |
|
  S. Maillet, T. Naas, S. Crepin, A.-M. Roque-Afonso, F. Lafay, S. Efstathiou, and M. Labetoulle Herpes Simplex Virus Type 1 Latently Infected Neurons Differentially Express Latency-Associated and ICP0 Transcripts. J. Virol., September 1, 2006; 80(18): 9310 - 9321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fowler, S. Marques, J. P. Simas, and S. Efstathiou ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency J. Gen. Virol., December 1, 2003; 84(12): 3405 - 3416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Thackray and R. Bujdoso PrPc Expression Influences the Establishment of Herpes Simplex Virus Type 1 Latency J. Virol., March 1, 2002; 76(5): 2498 - 2509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bridgeman, P. G. Stevenson, J. P. Simas, and S. Efstathiou A Secreted Chemokine Binding Protein Encoded by Murine Gammaherpesvirus-68 Is Necessary for the Establishment of a Normal Latent Load J. Exp. Med., August 6, 2001; 194(3): 301 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Arthur, C. G. Scarpini, V. Connor, R. H. Lachmann, A. M. Tolkovsky, and S. Efstathiou Herpes Simplex Virus Type 1 Promoter Activity during Latency Establishment, Maintenance, and Reactivation in Primary Dorsal Root Neurons In Vitro J. Virol., April 15, 2001; 75(8): 3885 - 3895. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Thackray and H. J. Field The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment J. Gen. Virol., October 1, 2000; 81(10): 2385 - 2396. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M. Thackray and H. J. Field Further evidence from a murine infection model that famciclovir interferes with the establishment of HSV-1 latent infections J. Antimicrob. Chemother., June 1, 2000; 45(6): 825 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Smith, R. H. Lachmann, and S. Efstathiou Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system J. Gen. Virol., March 1, 2000; 81(3): 649 - 662. [Abstract] [Full Text]
|
|
|
|
|
|
R. Lachmann, M Sadarangani, H. Atkinson, and S Efstathiou An analysis of herpes simplex virus gene expression during latency establishment and reactivation J. Gen. Virol., May 1, 1999; 80(5): 1271 - 1282. [Abstract]
|
|
|
|
 |
|
 A. M. Thackray and H. J. Field Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1555 - 1562. [Abstract] [Full Text]
|
|
|
|
|
|
J. Arthur, R Everett, I Brierley, and S Efstathiou Disruption of the 5' and 3' splice sites flanking the major latency- associated transcripts of herpes simplex virus type 1: evidence for alternate splicing in lytic and latent infections J. Gen. Virol., January 1, 1998; 79(1): 107 - 116. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
